"
Template:SupbiotechparisEn
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 35: | Line 35: | ||
!align="center"|[[Team:SupBiotech-Paris/Team#drapeau|Team]] | !align="center"|[[Team:SupBiotech-Paris/Team#drapeau|Team]] | ||
!align="center"|[[Team:SupBiotech-Paris/Project Management#drapeau|Project Management]] | !align="center"|[[Team:SupBiotech-Paris/Project Management#drapeau|Project Management]] | ||
| - | !align="center"|[[Team:SupBiotech-Paris/ | + | !align="center"|[[Team:SupBiotech-Paris/Gallery#drapeau|Gallery]] |
!align="center"|[[Team:SupBiotech-Paris/Acknowledgement#drapeau|Acknowledgement]] | !align="center"|[[Team:SupBiotech-Paris/Acknowledgement#drapeau|Acknowledgement]] | ||
|} | |} | ||
| Line 82: | Line 82: | ||
<div id="Partie" style="color: white; font-weight: bold; margin-bottom: -7px;">Ethic & Safety</div> | <div id="Partie" style="color: white; font-weight: bold; margin-bottom: -7px;">Ethic & Safety</div> | ||
| - | [[Team:SupBiotech-Paris/ | + | [[Team:SupBiotech-Paris/Ethic#drapeau|Ethic]] |
[[Team:SupBiotech-Paris/Safety#drapeau|Safety]] | [[Team:SupBiotech-Paris/Safety#drapeau|Safety]] | ||
Revision as of 14:45, 18 October 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
Biobricks Material & Method Bibliography
Ethic & Safety
